LCD L36815: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease — WPS
Policy LCD-L36815 · Hematology
New LCD impacts billing for myeloproliferative disease testing.
Code intelligence
D47.3 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code D47.3.
Elevated code riskView ICD-10 detail
Signal breakdown
3 shown · 3 total in platform
Risk: Elevated
0
Critical
0%
1
High
33%
2
Routine
67%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
LCD L39927: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms — Noridian
Policy LCD-L39927 · Hematology
New LCD for myeloproliferative neoplasm testing impacts billing.
LCD L34215: Lab: Flow Cytometry — Noridian
Policy LCD-L34215 · Clinical Laboratory
Noridian's Flow Cytometry LCD impacts billing guidelines.
Audit documentation
Building an audit file that includes D47.3?
The Tripwire Audit Pack exports 12 months of Hematology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Hematology audit pack — $349One-time purchase · not a subscription